Mar 012012
 
FDA approves first ever quadrivalent flu vaccine

The FDA has approved the first ever, quadrivalent flu vaccine. All flu vaccines in circulation today are trivalent, they protect against two strains of flu, generally to type A and one type B strain. The new vaccine will protect against four strains, two A and two B therefore increasing protection and the probability of the vaccine matching the actual flu strain in circulation. Here is the text of the full FDA Media Release (links added). FDA NEWS RELEASE For Immediate Release: Feb. 29, 2012 Media Inquiries: Rita Chappelle, 301-796-4672, rita.chappelle@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves first quadrivalent vaccine to prevent seasonal influenza FluMist Quadrivalent, a ———->FULL ARTICLE

Oct 242011
 
Medical News Today: Flu Vaccine Protects Pregnant Woman's Baby And Does Not Cause Miscarriage

READ THE FULL ARTICLE AT MEDICAL NEWS TODAY Apart from protecting a newborn infant from flu for four months, the flu vaccine does not raise the risk of miscarriage, Kathleen Neuzil, MD, member of the Infectious Disease Society of America’s Pandemic Influenza Task Force explained at their 49th Annual Meeting. Various presentations at the meeting are showing that pregnant mothers are getting the message not only about the flu shot’s importance, but also its safety. A newborn whose mother was not vaccinated is particularly vulnerable to flu because he/she is more likely not to be born with protective immunity and cannot be ———->FULL ARTICLE

Aug 132011
 
Universal Flu Vaccine Another Step Closer, But Still Far

On the Apr-Jun 2011 issue of  The Vaccine Times we reported on a new flu shot being tested which could do away with our need for yearly flu shots.  The vaccine candidate, called VAX102 is based on an antibody called F16 which can target a common protein shared by all Influenza A viruses which are the most virulent and the most prone to mutation influenza viruses. Recently U.S. scientists are reporting the finding of a new antibody which can tackle 30 of the 36 known strains of H1N1 (a virus of the A type) flu virus. The newly discovered antibody, ———->FULL ARTICLE

Jul 192011
 
Flu vaccine for 2011-2012 season approved by the FDA

The U.S. Food and Drug Administration (FDA) met in February to review data to determine the composition of the 2011-2012 season flu vaccine. Based on this review, the FDA recommended that this upcoming season’s vaccine contain the following three strains: an A/California/7/09 (H1N1)-like virus; * an A/Perth /16/2009 (H3N2)-like virus; a B/Brisbane/60/2008-like virus.         *A/California/7/09 (H1N1)-like virus is the pandemic (H1N1) 2009 influenza virus. This composition is identical to last season’s flu vaccine composition. This might mean that some healthy people may not need to take it this year, if they took last year’s shot. However, that needs to be determined ———->FULL ARTICLE

Universal flu vaccine?

 Posted by on February 8, 2011  1 Response »
Feb 082011
 
Universal flu vaccine?

UK’s The Guardian is reporting that test on humans of a novel universal flu vaccines have produced apparently positive results. If these results hold, and are replicated in larger scale studies, this would be excellent news indeed, as one vaccine would be able to target all the different strains of flu virus thus eliminating the never-ending guessing game that we are forced to engage in at the present time, which should hopefully lead to higher efficacy overall (by definition matching of the vaccine with the strain would no longer be an issue as it is currently). Scientists at Oxford University ———->FULL ARTICLE

Nov 272010
 

A new study has recently been published at the Lancet Infectious Diseases website which shows the trivalent inactivated flu vaccine is effective in reducing flu infections in children between 9 months and 3 years of age. Refer to the link below (requires free account set up with The Lancet Online) to read the abstract of the study. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Santtu Heinonen MD a, Heli Silvennoinen MD a, Pasi Lehtinen MD a, Raija Vainionpää PhD b, Thedi Ziegler PhD c, Dr Terho Heikkinen MD Study Summary ———->FULL ARTICLE

Oct 202010
 

- New guidelines by the American Academy of Allergy Asthma & Immunology say that individuals with egg allergies can safely receive the flu vaccine, without a skin test being performed first. Flu vaccines are grown in chicken eggs, which raised concerns about possible allergic reactions to residual egg protein. Up to now, precautionary steps were taken, which included vaccine skin testing, administration via a 2-step graded dose challenging (10%, followed by 90% of the age appropriate dose after a brief observation period), or stepwise desensitization. This latest AAAAI paper  “offers guidance in how to evaluate and treat the patient with egg ———->FULL ARTICLE